Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03391518
Other study ID # LSFG_WDT
Secondary ID
Status Active, not recruiting
Phase N/A
First received December 30, 2017
Last updated December 30, 2017
Start date February 5, 2017
Est. completion date January 31, 2018

Study information

Verified date December 2017
Source Augenabteilung Allgemeines Krankenhaus Linz
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study includes Caucasian patients with diagnosis of normal tension glaucoma and age- and sex-matched healthy individuals. Measurements of optic nerve head blood flow will be performed with laser speckle flowgraphy (LSFG). Also, the intraocular pressure (IOP), systolic and diastolic blood pressure, heart rate (HR), mean arterial pressure (MAP) as well as ocular perfusion pressure (OPP) will be evaluated. After baseline measurements individuals will be asked to ingest 800 ml of water in less than five minutes. Measurements will be repeated after 15, 30 and 45 minutes.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 18
Est. completion date January 31, 2018
Est. primary completion date December 4, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years and older
Eligibility Inclusion Criteria:

- presence of glaucomatous optic disc changes in biomicroscopy and visual field defects or abnormal circumpapillary retinal nerve fibre layer (RNFL) thinning (evaluated by OCT as defined by the on-board software)

- IOP = 21mmHg without therapy

- normal open angle in a gonioscopic examination

- age > 40 years

Exclusion Criteria:

- IOP > 21 mmHg in patients' history

- ametropia > 6 diopters

- cataract with severity greater than grade 2 of the lens opacities classification system (LOCS) classification

- presence of corneal opacities

- uncontrolled hypertension with systolic blood pressure (SBP) > 165mmHg and/or diastolic blood pressure (DBP) > 100mmHg

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Water drinking test
Ingestion of 800 ml water in less than 5 minutes.

Locations

Country Name City State
Austria AKh Linz Linz Oberösterreich

Sponsors (1)

Lead Sponsor Collaborator
Augenabteilung Allgemeines Krankenhaus Linz

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in ONH blood flow induced by water drinking test ONH blood flow evaluated by laser speckle flowgraphy baseline, after 15, 30 and 45 minutes
See also
  Status Clinical Trial Phase
Completed NCT01487655 - Waveform Analysis of the Doppler Curve of Ophthalmic Arteries in Glaucoma Patients N/A
Terminated NCT02891317 - Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma
Recruiting NCT03098316 - Metabolomics in Surgical Ophthalmological Patients N/A
Completed NCT01391247 - Validation of Retinal Oximetry in Glaucoma Patients: a Structural and Functional Correlation N/A
Completed NCT01209624 - Observational Study of the Long-term Effect of Latanoprost in Normal Tension Glaucoma